HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common stock, $.01 par value per share
Shares outstanding
46,480,294
Total 13F shares
51,283,498
Share change
+858,817
Total reported value
$4,486,016,605
Put/Call ratio
28%
Price per share
$87.48
Number of holders
253
Value change
+$62,307,595
Number of buys
125
Number of sells
149

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q1 2019

As of 31 Mar 2019, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 253 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,283,498 shares. The largest 10 holders included BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Jackson Square Partners, LLC, Neuberger Berman Group LLC, Capital Research Global Investors, HealthCor Management, L.P., and AQR CAPITAL MANAGEMENT LLC. This page lists 253 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.